Pharmabiz18h
Acelyrin to present positive results from global phase 3 trial of izokibep in hidradenitis suppurativa at EADV 2024
Acelyrin to present positive results from global phase 3 trial of izokibep in hidradenitis suppurativa at EADV 2024: Los Angeles Saturday, September 21, 2024, 18:00 Hrs [IST] Acel ...
Pharmabiz22h
Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease
Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...
Pharmabiz19h
ANGLE signs agreement with Recursion Pharma to expand pharma services business
ANGLE signs agreement with Recursion Pharma to expand pharma services business: London Saturday, September 21, 2024, 17:00 Hrs [IST] ANGLE plc, a world-leading liquid biopsy compa ...
Pharmabiz21h
EMA committee recommends Novo Nordisk’s Wegovy label update to reflect reduced heart failure symptoms and improved physical function
Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...
Pharmabiz20h
NIH-led studies point to potential development of a cataract drug
NIH-led studies point to potential development of a cataract drug: Bethesda, Maryland Saturday, September 21, 2024, 16:00 Hrs [IST] Researchers at the National Institutes of Healt ...
Pharmabiz23h
Indian Cancer Genome Atlas launches the country’s first comprehensive cancer multi-omics data portal
Indian Cancer Genome Atlas launches the country’s first comprehensive cancer multi-omics data portal: Our Bureau, Mumbai Saturday, September 21, 2024, 13:30 Hrs [IST] The Indian ...
Pharmabiz23h
Tonix Pharma receives US patent covering the intranasal delivery of Tosymra to treat migraine
Tonix Pharma receives US patent covering the intranasal delivery of Tosymra to treat migraine: Chatham, New Jersey Saturday, September 21, 2024, 13:00 Hrs [IST] Tonix Pharmaceutic ...